Acorda Therapeutics, Inc. (ACOR): Price and Financial Metrics

Acorda Therapeutics, Inc. (ACOR): $13.05

0.45 (-3.33%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

C

Add ACOR to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#21 of 345

in industry

ACOR Price/Volume Stats

Current price $13.05 52-week high $24.20
Prev. close $13.50 52-week low $8.98
Day low $13.05 Volume 600
Day high $13.50 Avg. volume 3,529
50-day MA $15.20 Dividend yield N/A
200-day MA $13.55 Market Cap 16.21M

ACOR Stock Price Chart Interactive Chart >

ACOR POWR Grades

  • Growth is the dimension where ACOR ranks best; there it ranks ahead of 96.85% of US stocks.
  • ACOR's strongest trending metric is Value; it's been moving up over the last 125 days.
  • ACOR's current lowest rank is in the Stability metric (where it is better than 14.33% of US stocks).

ACOR Stock Summary

  • ACOR has a higher market value than just 8.09% of US stocks; more precisely, its current market capitalization is $18,010,421.
  • ACOR's price/sales ratio is 0.16; that's higher than the P/S ratio of merely 4.24% of US stocks.
  • The volatility of ACORDA THERAPEUTICS INC's share price is greater than that of 94.04% US stocks with at least 200 days of trading history.
  • If you're looking for stocks that are quantitatively similar to ACORDA THERAPEUTICS INC, a group of peers worth examining would be NXTP, CREX, AXTA, AYTU, and ANGI.
  • ACOR's SEC filings can be seen here. And to visit ACORDA THERAPEUTICS INC's official web site, go to www.acorda.com.

ACOR Valuation Summary

  • ACOR's price/sales ratio is 0.2; this is 90.91% lower than that of the median Healthcare stock.
  • ACOR's price/earnings ratio has moved up 0.9 over the prior 218 months.

Below are key valuation metrics over time for ACOR.

Stock Date P/S P/B P/E EV/EBIT
ACOR 2023-12-29 0.2 0.3 -1.2 13.8
ACOR 2023-12-28 0.2 0.3 -1.1 13.7
ACOR 2023-12-27 0.2 0.3 -1.1 13.6
ACOR 2023-12-26 0.2 0.3 -1.1 13.7
ACOR 2023-12-22 0.2 0.3 -1.2 13.8
ACOR 2023-12-21 0.2 0.3 -1.2 13.7

ACOR Growth Metrics

    The 2 year price growth rate now stands at -84.38%.
  • Its year over year net income to common stockholders growth rate is now at 24.93%.
  • Its 4 year net income to common stockholders growth rate is now at -337.4%.
ACOR's revenue has moved down $27,834,000 over the prior 15 months.

The table below shows ACOR's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 124.063 -26.75 -105.625
2022-06-30 122.008 -33.923 -118.842
2022-03-31 122.742 -28.097 -95.024
2021-12-31 129.071 -41.348 -103.954
2021-09-30 130.263 -43.14 -166.434
2021-06-30 151.897 -37.033 -132.016

ACOR's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • ACOR has a Quality Grade of C, ranking ahead of 72.56% of graded US stocks.
  • ACOR's asset turnover comes in at 0.251 -- ranking 176th of 680 Pharmaceutical Products stocks.
  • BDSI, INVA, and CALA are the stocks whose asset turnover ratios are most correlated with ACOR.

The table below shows ACOR's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.251 0.695 -0.414
2021-03-31 0.232 0.729 -0.327
2020-12-31 0.217 0.781 -0.207
2020-09-30 0.221 0.810 0.173
2020-06-30 0.202 0.830 -0.419
2020-03-31 0.194 0.831 -0.393

ACOR Price Target

For more insight on analysts targets of ACOR, see our ACOR price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $10.00 Average Broker Recommendation 1.5 (Moderate Buy)

Acorda Therapeutics, Inc. (ACOR) Company Bio


Acorda Therapeutics is a biotechnology company focused on developing therapies that restore function and improve the lives of people with neurological disorders. The company was founded in 1995 and is based in Ardsley, New York.


ACOR Latest News Stream


Event/Time News Detail
Loading, please wait...

ACOR Latest Social Stream


Loading social stream, please wait...

View Full ACOR Social Stream

Latest ACOR News From Around the Web

Below are the latest news stories about ACORDA THERAPEUTICS INC that investors may wish to consider to help them evaluate ACOR as an investment opportunity.

Acorda Therapeutics, Inc. (NASDAQ:ACOR) Q3 2023 Earnings Call Transcript

Acorda Therapeutics, Inc. (NASDAQ:ACOR) Q3 2023 Earnings Call Transcript November 13, 2023 Operator: Welcome to Acorda Therapeutics Third Quarter 2023 Financial and Business Update. At this time, all participants are in a listen-only mode. There will be a question-and-answer session to follow. Please be advised that this call is being recorded at the company’s request. […]

Yahoo | November 14, 2023

Acorda Therapeutics Reports Third Quarter 2023 Financial Results

PEARL RIVER, N.Y., November 13, 2023--Acorda Therapeutics Reports Third Quarter 2023 Financial Results

Yahoo | November 13, 2023

Acorda Third Quarter 2023 Update: Webcast/Conference Call Scheduled for November 13, 2023

PEARL RIVER, N.Y., November 06, 2023--Acorda Third Quarter 2023 Update: Webcast/Conference Call Scheduled for November 13, 2023

Yahoo | November 6, 2023

Acorda Therapeutics Announces Biopas Laboratories Submission to Regulatory Agencies in Six Latin American Countries for Approval of INBRIJA®

PEARL RIVER, N.Y., November 06, 2023--Acorda Therapeutics Announces Biopas Laboratories Submission to Regulatory Agencies in Six Latin American Countries for Approval of INBRIJA®

Yahoo | November 6, 2023

Acorda Therapeutics (ACOR): A Comprehensive Analysis of Its Market Value

Unveiling the Intrinsic Value of Acorda Therapeutics

Yahoo | August 28, 2023

Read More 'ACOR' Stories Here

ACOR Price Returns

1-mo -23.44%
3-mo 33.57%
6-mo -1.73%
1-year -29.61%
3-year -89.69%
5-year -99.19%
YTD -13.52%
2023 -1.59%
2022 -67.92%
2021 -42.28%
2020 -66.17%
2019 -86.91%

Continue Researching ACOR

Here are a few links from around the web to help you further your research on Acorda Therapeutics Inc's stock as an investment opportunity:

Acorda Therapeutics Inc (ACOR) Stock Price | Nasdaq
Acorda Therapeutics Inc (ACOR) Stock Quote, History and News - Yahoo Finance
Acorda Therapeutics Inc (ACOR) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!